Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Efficacy of Monthly Subcutaneous Administration of ION904 in Participants With Uncontrolled Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating monthly subcutaneous ION904 for safety, tolerability, and efficacy in adults with uncontrolled hypertension; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• ION904

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Hypertension | Phase 2 | Status: COMPLETED